Alere extends tender offer for Axis-Shield stock as shareholders stand their ground
This article was originally published in Clinica
Executive Summary
Alere's hostile takeover attempt of Axis-Shield has not borne much fruit so far, as shareholders of the Anglo-Nordic in vitro diagnostics firm appear to be hanging onto their stock.